Compare WVE & EIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WVE | EIG |
|---|---|---|
| Founded | 2012 | 2000 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 911.6M |
| IPO Year | 2015 | 2006 |
| Metric | WVE | EIG |
|---|---|---|
| Price | $5.06 | $48.94 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 16 | 0 |
| Target Price | ★ $29.81 | N/A |
| AVG Volume (30 Days) | ★ 3.2M | 143.4K |
| Earning Date | 04-28-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.99% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.07 |
| Revenue | $3,704,000.00 | ★ $858,700,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $85.67 | $1.26 |
| P/E Ratio | ★ N/A | $23.68 |
| Revenue Growth | ★ 149.43 | N/A |
| 52 Week Low | $5.01 | $35.73 |
| 52 Week High | $21.73 | $52.59 |
| Indicator | WVE | EIG |
|---|---|---|
| Relative Strength Index (RSI) | 39.27 | 50.83 |
| Support Level | $5.02 | $48.30 |
| Resistance Level | $6.39 | $52.32 |
| Average True Range (ATR) | 0.31 | 0.97 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 2.26 | 76.20 |
WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations through its wholly owned subsidiaries.